These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 389454)

  • 1. [Medical treatment of inflammatory bowel diseases in the light of controlled clinical trials (author's transl)].
    Maratka Z
    Cesk Gastroenterol Vyz; 1979 Jul; 33(5):292-9. PubMed ID: 389454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inflammatory intestinal diseases--determination of activity and new pharmacotherapeutic approaches].
    Pouzar A
    Sb Lek; 1988 May; 90(5):133-9. PubMed ID: 3413444
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of inflammatory diseases of the colon with salazopyrine].
    Chevrel B
    Med Chir Dig; 1982; 11(3):227-30. PubMed ID: 6124663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inflammatory diseases of the colon and salazopyrine. Value of long term treatment].
    Chevrel B
    Med Chir Dig; 1976; 5(5):313-7. PubMed ID: 12427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V; Munkholm P
    Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects of inflammatory diseases of the large bowel with reference to coloscopy (author's transl)].
    Seifert E
    Radiologe; 1976 Nov; 16(11):484-8. PubMed ID: 1005713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: Crohn's disease and levamisole].
    Bertrand J; Renoux G; Renoux M; Palat A
    Nouv Presse Med; 1974 Oct; 3(35):2265. PubMed ID: 4617861
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

  • 11. [New developments in the treatment of inflammatory bowel diseases. What is certain?].
    Feurle GE
    Z Gastroenterol Verh; 1990 Apr; 25():150-2. PubMed ID: 1694355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in the topical steroid treatment of inflammatory bowel diseases].
    Díaz Blasco J; Robledo Andrés P
    Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Budesonide and inflammatory bowel disease].
    Gomollón F; Hinojosa J; Nos P
    Gastroenterol Hepatol; 1999 Dec; 22(10):525-32. PubMed ID: 10650668
    [No Abstract]   [Full Text] [Related]  

  • 16. Some effects of drug laws and regulations on the practice of medicine, with particular emphasis on inflammatory bowel disease.
    Goldstein F
    Am J Gastroenterol; 1988 Oct; 83(10):1091-7. PubMed ID: 3421219
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of recurrence of chronic inflammatory bowel diseases].
    Dölle W; Hartmann F
    Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclosporin--a solution or dead end in treatment of chronic inflammatory bowel diseases?].
    Fischbach W
    Z Gastroenterol; 1995 May; 33(5):275-6. PubMed ID: 7610696
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in inflammatory diseases of the colon (author's transl)].
    Egger G
    Ther Umsch; 1974 Nov; 31(11):804-9. PubMed ID: 4154520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.